Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Cisplatin and temozolomide combination in the treatment of supratentorial anaplastic ependymoma.

Lombardi G, Pambuku A, Bellu L, Della Puppa A, Rumanò L, Gardiman MP, Pomerri F, Zagonel V.

Chemotherapy. 2013;59(3):176-80. doi: 10.1159/000355662. Epub 2013 Oct 31.

PMID:
24192541
2.

Response to temozolomide in supratentorial multifocal recurrence of malignant ependymoma.

Freyschlag CF, Tuettenberg J, Lohr F, Thomé C, Schmieder K, Seiz M.

Anticancer Res. 2011 Mar;31(3):1023-5.

PMID:
21498732
3.

Temozolomide as salvage treatment for recurrent intracranial ependymomas of the adult: a retrospective study.

Rudà R, Bosa C, Magistrello M, Franchino F, Pellerino A, Fiano V, Trevisan M, Cassoni P, Soffietti R.

Neuro Oncol. 2016 Feb;18(2):261-8. doi: 10.1093/neuonc/nov167. Epub 2015 Aug 30.

4.

Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymoma.

Chamberlain MC, Johnston SK.

Cancer. 2009 Oct 15;115(20):4775-82. doi: 10.1002/cncr.24524.

5.

Chemotherapy for intracranial ependymoma in adults.

Gramatzki D, Roth P, Felsberg J, Hofer S, Rushing EJ, Hentschel B, Westphal M, Krex D, Simon M, Schnell O, Wick W, Reifenberger G, Weller M.

BMC Cancer. 2016 Apr 23;16:287. doi: 10.1186/s12885-016-2323-0.

6.

A case report of a recurrent intracranial ependymoma treated with temozolomide in remission 10 years after completing chemotherapy.

Rehman S, Brock C, Newlands ES.

Am J Clin Oncol. 2006 Feb;29(1):106-7. No abstract available.

PMID:
16462515
7.

Temozolomide Treatment for Pediatric Refractory Anaplastic Ependymoma with Low MGMT Protein Expression.

Komori K, Yanagisawa R, Miyairi Y, Sakashita K, Shiohara M, Fujihara I, Morita D, Nakamura T, Ogiso Y, Sano K, Shirahata M, Fukuoka K, Ichimura K, Shigeta H.

Pediatr Blood Cancer. 2016 Jan;63(1):152-5. doi: 10.1002/pbc.25696. Epub 2015 Aug 25.

PMID:
26305586
8.

Survival and prognostic factors following radiation therapy and chemotherapy for ependymomas in children: a report of the Children's Cancer Group.

Robertson PL, Zeltzer PM, Boyett JM, Rorke LB, Allen JC, Geyer JR, Stanley P, Li H, Albright AL, McGuire-Cullen P, Finlay JL, Stevens KR Jr, Milstein JM, Packer RJ, Wisoff J.

J Neurosurg. 1998 Apr;88(4):695-703.

PMID:
9525716
9.
10.

Radiation-induced anaplastic ependymoma with a remarkable clinical response to temozolomide: a case report.

Khoo HM, Kishima H, Kinoshita M, Goto Y, Kagawa N, Hashimoto N, Maruno M, Yoshimine T.

Br J Neurosurg. 2013 Apr;27(2):259-61. doi: 10.3109/02688697.2012.741740. Epub 2012 Nov 19.

PMID:
23163298
11.

Neoadjuvant cisplatin plus temozolomide versus standard treatment in patients with unresectable glioblastoma or anaplastic astrocytoma: a differential effect of MGMT methylation.

Capdevila L, Cros S, Ramirez JL, Sanz C, Carrato C, Romeo M, Etxaniz O, Hostalot C, Massuet A, Cuadra JL, Villà S, Balañà C.

J Neurooncol. 2014 Mar;117(1):77-84. doi: 10.1007/s11060-013-1352-7. Epub 2014 Jan 7.

PMID:
24395350
12.

Cisplatin and temozolomide combination in the treatment of leptomeningeal carcinomatosis from ethmoid sinus intestinal-type adenocarcinoma.

Lombardi G, Zustovich F, Della Puppa A, Borgato L, Orvieto E, Manara R, Cecchin D, Berti F, Farina P, Gardiman MP, Scienza R, Zagonel V.

J Neurooncol. 2011 Aug;104(1):381-6. doi: 10.1007/s11060-010-0484-2. Epub 2010 Dec 8.

PMID:
21140282
13.

Prolonged administration of temozolomide in adult patients with anaplastic glioma.

Freyschlag CF, Smolczyk DR, Janzen E, Schmieder K, Thomé C, Lohr F, Wenz F, Weiss C, Tuettenberg J, Seiz M.

Anticancer Res. 2011 Nov;31(11):3873-7.

PMID:
22110212
14.

Temozolomide chemotherapy of patients with recurrent anaplastic astrocytomas and glioblastomas.

Sipos L, Vitanovics D, Afra D.

Ideggyogy Sz. 2004 Nov 20;57(11-12):394-9.

PMID:
15662767
15.

Bevacizumab for recurrent ependymoma.

Green RM, Cloughesy TF, Stupp R, DeAngelis LM, Woyshner EA, Ney DE, Lassman AB.

Neurology. 2009 Nov 17;73(20):1677-80. doi: 10.1212/WNL.0b013e3181c1df34.

16.

Temozolomide chemotherapy in recurrent oligodendroglioma.

van den Bent MJ, Keime-Guibert F, Brandes AA, Taphoorn MJ, Kros JM, Eskens FA, Carpentier AF.

Neurology. 2001 Jul 24;57(2):340-2.

PMID:
11468326
17.

Intracavitary chemotherapy (Gliadel) and oral low-dose etoposide for recurrent anaplastic ependymoma.

Sardi I, Sanzo M, Giordano F, Sandri A, Mussa F, Donati PA, Genitori L.

Oncol Rep. 2008 May;19(5):1219-23.

PMID:
18425379
18.

Role of radiotherapy in anaplastic ependymoma in children under age of 3 years: results of the prospective German brain tumor trials HIT-SKK 87 and 92.

Timmermann B, Kortmann RD, Kühl J, Rutkowski S, Dieckmann K, Meisner C, Bamberg M.

Radiother Oncol. 2005 Dec;77(3):278-85. Epub 2005 Nov 21.

PMID:
16300848
19.

Salvage chemotherapy with CPT-11 for recurrent temozolomide-refractory anaplastic astrocytoma.

Chamberlain MC, Wei-Tsao DD, Blumenthal DT, Glantz MJ.

Cancer. 2008 May 1;112(9):2038-45. doi: 10.1002/cncr.23404.

20.

The use of neoadjuvant chemotherapy to achieve complete surgical resection in recurring supratentorial anaplastic ependymoma.

Valera ET, Machado HR, Santos AC, de Oliveira RS, Araújo D, Neder L, Tone LG.

Childs Nerv Syst. 2005 Mar;21(3):230-3. Epub 2004 Aug 27.

PMID:
15338180

Supplemental Content

Support Center